Targeting STAT3 Enzyme for Cancer Treatment

被引:0
|
作者
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
关键词
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I
10.2174/0113895575254012231024062619
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码:1252 / 1261
页数:10
相关论文
共 50 条
  • [31] Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
    Sen, Malabika
    Joyce, Sonali
    Panahandeh, Mary
    Li, Changyou
    Thomas, Sufi M.
    Maxwell, Jessica
    Wang, Lin
    Gooding, William E.
    Johnson, Daniel E.
    Grandis, Jennifer R.
    CLINICAL CANCER RESEARCH, 2012, 18 (18) : 4986 - 4996
  • [32] Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
    Wei, Ning
    Li, Jun
    Fang, Cheng
    Chang, Jin
    Xirou, Vasiliki
    Syrigos, Nick K.
    Marks, Benjamin J.
    Chu, Edward
    Schmitz, John C.
    ONCOGENE, 2019, 38 (10) : 1676 - 1687
  • [33] MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3
    Zhong, Lou
    Sun, Siyuan
    Shi, Jiahai
    Cao, Fei
    Han, Xiao
    Chen, Zhong
    TUMOR BIOLOGY, 2017, 39 (06)
  • [34] STAT3 and STAT5 Activation in Solid Cancers
    Igelmann, Sebastian
    Neubauer, Heidi A.
    Ferbeyre, Gerardo
    CANCERS, 2019, 11 (10)
  • [35] Docoxahexaenoic Acid Induces Apoptosis of Pancreatic Cancer Cells by Suppressing Activation of STAT3 and NF-κB
    Park, Mirae
    Lim, Joo Weon
    Kim, Hyeyoung
    NUTRIENTS, 2018, 10 (11)
  • [36] Identification of four STAT3 isoforms and functional investigation of IL-6/JAK2/STAT3 pathway in blunt snout bream (Megalobrama amblycephala)
    Wang, Jixiu
    Sun, Qianhui
    Wu, Jiaqi
    Tian, Wanping
    Wang, Huanling
    Liu, Hong
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2022, 135
  • [37] MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3
    Shan, Dan
    Shang, Yumin
    Hu, Tongxiu
    ONCOLOGY RESEARCH, 2019, 27 (03) : 349 - 358
  • [38] STAT3 and apoptosis challenges in cancer
    Fathi, Nazanin
    Rashidi, Golnaz
    Khodadadi, Ali
    Shahi, Shahriar
    Sharifi, Simin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 117 : 993 - 1001
  • [39] The Role of STAT3 in Thyroid Cancer
    Sosonkina, Nadiya
    Starenki, Dmytro
    Park, Jong-In
    CANCERS, 2014, 6 (01): : 526 - 544
  • [40] STAT3 pathway as a molecular target for resveratrol in breast cancer treatment
    Kohandel, Zeynab
    Farkhondeh, Tahereh
    Aschner, Michael
    Pourbagher-Shahri, Ali Mohammad
    Samarghandian, Saeed
    CANCER CELL INTERNATIONAL, 2021, 21 (01)